Catalyst Pharmaceuticals Inc header image

Catalyst Pharmaceuticals Inc

CPRX

Equity

ISIN null / Valor 2649177

NASDAQ (2026-07-02)
USD 31.45+0.03%

Catalyst Pharmaceuticals Inc
UMushroom community rating:

star star star star star
0.00 0 votes No rating yet
NegativeNeutralPositive

About company

Catalyst Pharmaceuticals Inc. is a commercial-stage biopharmaceutical company that specializes in the in-licensing, development, and commercialization of innovative treatments for patients with rare diseases. The company's primary focus is on addressing unmet medical needs by bringing novel therapeutic options to market. Catalyst Pharmaceuticals leverages its expertise in drug development and regulatory processes to advance its pipeline of products, aiming to improve the quality of life for individuals affected by rare and debilitating conditions.

Summarized from source with an LLMView SourceSector: Healthcare

Latest Results ():

Summarized from source with an LLMView Source

Key figures

46.6%1Y
134%3Y
457%5Y

Performance

32.8%1Y
39.5%3Y
48.1%5Y

Volatility

Market cap

3849 M

Market cap (USD)

Daily traded volume (Shares)

1,616,291

Daily traded volume (Shares)

1 day high/low

21.34 / 20.93

1 day high/low (USD)

52 weeks high/low

0.00 / 0.00

52 weeks high/low (USD)

Dividend ex-date

01 January, 2022

Dividend ex-date

Dividend

0.00

Dividend (USD)

Dividend yield (p.a.)

0.00%

Dividend yield (p.a.)

0.002022
0.002023
0.002024

Est dividend (USD)

0.00%2022
0.00%2023
0.00%2024

Est dividend yield

P/E ratio

10.00

P/E ratio

00.002022
00.002023
00.002024

Est P/E ratio

EPS

0.00

EPS (USD)

0.002022
0.002023
0.002024

Est EPS (USD)

Ratings & reviews

star star star star star

0.00

0 votes
Performance:
starstarstarstarstar
0.00
Innovation:
starstarstarstarstar
0.00
Society:
starstarstarstarstar
0.00
Nature:
starstarstarstarstar
0.00

EQUITIES OF THE SAME SECTOR

Ultragenyx Pharmaceutical Inc
Ultragenyx Pharmaceutical Inc Ultragenyx Pharmaceutical Inc Valor: 22860122
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
3.37%USD 33.47
Pacira BioSciences Inc
Pacira BioSciences Inc Pacira BioSciences Inc Valor: 12338490
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
1.44%USD 25.39
Cupid Limited
Cupid Limited Cupid Limited Valor: 133949722
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
3.67%INR 198.90
Laurus Labs Ltd.
Laurus Labs Ltd. Laurus Labs Ltd. Valor: 56464789
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
1.09%INR 1,541.75
Alembic Pharmaceuticals Limited
Alembic Pharmaceuticals Limited Alembic Pharmaceuticals Limited Valor: 11500585
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
0.91%INR 822.60
Syngene International Ltd.
Syngene International Ltd. Syngene International Ltd. Valor: 28993609
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
0.09%INR 440.25
Boston Scientific Corp
Boston Scientific Corp Boston Scientific Corp Valor: 913577
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
4.83%USD 45.14
Cohance Lifesciences Ltd
Cohance Lifesciences Ltd Cohance Lifesciences Ltd Valor: 46346459
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
0.62%INR 454.85
Teladoc Health Inc
Teladoc Health Inc Teladoc Health Inc Valor: 28438140
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
1.10%USD 9.20
Rhythm Pharmaceuticals Inc
Rhythm Pharmaceuticals Inc Rhythm Pharmaceuticals Inc Valor: 25337263
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
3.41%USD 114.17